147293-16-1 Usage
Uses
Used in Organic Synthesis:
8-Nitro-7-methylaminoquinoline is used as a synthetic building block for the creation of various organic compounds. Its unique structure and properties allow it to participate in a range of chemical reactions, facilitating the synthesis of complex molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 8-Nitro-7-methylaminoquinoline is used as an intermediate in the development of new drugs. Its chemical versatility enables it to be a key component in the synthesis of various medicinal compounds, contributing to the advancement of novel therapeutic agents.
Used in Dye and Pigment Industry:
The deep-orange crystalline nature of 8-Nitro-7-methylaminoquinoline makes it a suitable candidate for use in the dye and pigment industry. It can be employed in the production of vibrant and stable colorants for various applications, such as textiles, plastics, and printing inks.
Used in Research and Development:
8-Nitro-7-methylaminoquinoline is also used in research and development settings, where its unique properties can be explored for potential applications in new technologies and innovations. Its role in organic synthesis and chemical reactions makes it a valuable tool for scientists and researchers working on the development of new materials and compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 147293-16-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,2,9 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 147293-16:
(8*1)+(7*4)+(6*7)+(5*2)+(4*9)+(3*3)+(2*1)+(1*6)=141
141 % 10 = 1
So 147293-16-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H9N3O2/c1-11-8-5-4-7-3-2-6-12-9(7)10(8)13(14)15/h2-6,11H,1H3
147293-16-1Relevant academic research and scientific papers
HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
-
, (2012/07/27)
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
THE SYNTHESIS OF THREE ISOMERS OF THE FOOD CARCINOGEN IQ
Ronne, Erik,Grivas, Spiros
, p. 101 - 105 (2007/10/02)
2-Amino-3-methyl-3H-imidazoquinoline, 2-amino-3-methyl-3H-imidazoisoquinoline and 2-amino-3-methyl-3H-imidazoisoquinoline were synthesized from 7-methoxyquinoline, 6- and 7-methoxyisoquinolines in 21-28percent overall yields.
Oxidative Methylamination of Nitroquinolines
Wozniak, Marian,Grzegozek, Maria
, p. 823 - 830 (2007/10/02)
3-, 5-, 6-, 7- and 8-nitroquinoline as well as 5,7- and 6,8-dinitroquinoline are methylaminated with a liquid methylamine solution of potassium permanganate (LMA/PP) to the corresponding mono- and bis(methylamino)-substituted compounds. 2-Nitroquinoline is aminated with LMA/PP to 2-(methylamino)quinoline.The intermediate methylamino ?-adducts of 3-nitro- and 5,7- and 6,8-dinitroquinoline are detected by 1H-NMR spectroscopy.Quantum chemical calculations for the mononitroquinolines suggest that the experimentally observed regioselectivity of the methylamination is controlled by an interaction of frontal molecular orbitals (FMO) of the reagents. Key Words: Methylaminations / ?-Adducts, methylamino / Calculations, FMO / Quinolines / Aminations
